95%, relative risk 1.02 (95% confidence interval [CI], 0.96 to 1.11), with dry mouth, somnolence, dizziness and weight gain being the most frequently reported adverse events. There was a trend towards increased withdrawals due to adverse events with cyclobenzaprine vs amitriptyline at 16% vs.